Showing results (21-30 of 88) with videos related to
Sort By:
Pageof 9
Cancer Letters|April 14, 1995
Serum CD44 splice variants in cervical cancer patientsC Kainz, C Tempfer, S Winkler, et al.Cancer|July 15, 1996
Prognostic value of immunohistochemically detected CD44 expression in patients with carcinoma of the vulvaC Tempfer, G Gitsch, G Haeusler, et al.Anticancer Research|May 25, 2004
Topotecan as a continuous infusion over 14 days in recurrent ovarian cancer patientsD Denschlag, D Watermann, K Hörig, et al.Archives of Gynecology and Obstetrics|January 1, 1995
Influence of age and human papillomavirus-infection on reliability of cervical cytopathologyC Kainz, C Tempfer, G Gitsch, et al.Geburtshilfe Und Frauenheilkunde|November 12, 2015
Progression or Regression? - Strengths and Weaknesses of the New Munich Nomenclature III for Cervix CytologyZ Hilal, C Tempfer, S Schiermeier, et al.Obstetrics and Gynecology|June 23, 2000
Serum soluble Fas levels in ovarian cancerL Hefler, K Mayerhofer, A Nardi, et al.Journal of the Society for Gynecologic Investigation|February 27, 2001
Maternal basic fibroblast growth factor serum levels are associated with pregnancy-induced hypertensionC Kurz, L Hefler, H Zeisler, et al.Geburtshilfe Und Frauenheilkunde|August 1, 1995
[The Bethesda system--an improvement in classification of cervix cytology?]C Kainz, C Tempfer, D Bancher, et al.Acta Obstetricia Et Gynecologica Scandinavica|March 25, 1998
Present state of diagnostics and therapy in female urinary incontinenceG Haeusler, C Sam, D Dørfler, et al.Anticancer Research|July 1, 1996
Expression of the adhesion molecule CD44v3 is a prognostic factor in vulvar carcinomaC Tempfer, G Gitsch, E Hanzal, et al.Pageof 9